GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Astria Therapeutics Inc (STU:2090) » Definitions » Cash Receipts from Operating Activities

Astria Therapeutics (STU:2090) Cash Receipts from Operating Activities


View and export this data going back to 2017. Start your Free Trial

What is Astria Therapeutics Cash Receipts from Operating Activities?

Cash Receipts from Operating Activities only applicable to companies reporting Cash Flow from Operations in direct method.


Astria Therapeutics (STU:2090) Business Description

Industry
Traded in Other Exchanges
Address
75 State Street, Suite 1400, Boston, MA, USA, 02109
Astria Therapeutics Inc is a biopharmaceutical company engaged to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Its lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.